
Expanding Horizons and Gaining Insights on T-DXd and Sacituzumab in Breast Cancer
The treatment paradigm for both HER2-positive, HER2-negative, and hormone receptor–positive breast cancer continues to advance at a rapid pace, with many recently approved treatment options. Among the most impactful recent developments are the antibody- …